News

WRF gifts $2M to ISB to advance P4 Medicine

PRESS RELEASE from Washington Research Foundation:

Sept. 30, 2015, Seattle –– Washington Research Foundation (WRF), which supports groundbreaking technology in the life sciences, physical sciences and information sciences in Washington State, announced today that it will provide the Institute for Systems Biology (ISB) with $2 million in funding to bring increased research power to Seattle, and help place this community at the center of the coming transformation of the health care
system. The funding will help accelerate ISB’s P4 biomedical research, which is catalyzing a new industry – scientific wellness – and establish Seattle as its epicenter. P4 medicine is predictive, preventive,
personalized and participatory and has two central thrusts – quantifying wellness and demystifying disease. The current healthcare industry focuses 98 percent of its efforts and resources on addressing disease. In contrast, P4 medicine will enable the quantification of wellness and promises a revolution in the healthcare system – from a focus on disease to a focus on wellness. This has the potential to save the healthcare systems billions of dollars.

Read full press release…

Recent Articles

  • Priyanka Baloni

    Bile Acids Provide More Evidence of the Gut Microbiome’s Effect on Alzheimer’s Disease

    ISB researchers and their collaborators are looking beyond the one-drug, one-solution approach that has thus far failed in Alzheimer’s disease research. Instead, they are focusing on other promising research avenues, such as the possible role of the gut microbiome in dementia.

  • Overall composition of gut microbiome in participants

    Variations in the Microbiome Associated with Health, Disease

    ISB researchers examined the associations between the gut microbiomes of about 3,400 people and roughly 150 host characteristics. The team looked at diet, medication use, clinical blood markers, and other lifestyle and clinical factors, and found evidence that variations of the gut microbiome are associated with health and disease.

  • Andrew Magis

    ISB Researchers Identify Signals of Metastatic Cancer Years Prior to Diagnosis

    By analyzing blood plasma samples taken at several time points, ISB researchers have identified specific proteins that persistently presented as outliers and signaled metastatic cancer well before patients were diagnosed. The findings were published in the journal Scientific Reports.